CenExel’s Post

View organization page for CenExel, graphic

9,357 followers

On June 7th, the Psychiatric Times featured an article by Kenneth Bender titled, "Investigational Antipsychotic Demonstrates Efficacy Without Blocking Dopamine Receptor." David Walling, PhD, Chief Clinical Officer of CenExel CNS, was highlighted as a Principal Investigator in the study. To read the article, click here: https://lnkd.in/dn29dNuZ. Congratulations, Dr. Walling! www.cenexel.com #CenExel #InTheNews #ClinicalResearch

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics